Essay - Pfizer SWOT Pfizer—a SWOT Analysis Strengths Pfizer is One of...


Copyright Notice

Pfizer SWOT

Pfizer—a ***** Analysis

*****

Pfizer is one of the world's leading research pharmaceutical companies and also one ***** the ***** most profitable companies. It has a well-respected name known all over the world and commands some of the top research, advertising, financial, and marketing talent. It produces two of the most well-known name-brand drugs, Viagra and Lipitor in America today. Even ***** American Heart Association recommends the use of ***** such as Lipitor to reduce cholesterol when diet ***** exercise fail ***** reduce this common health problem. High cholesterol ***** a common ***** problem is only likely to increase with the rapidly aging population—and the rise in obesity levels (Berenson, 2007).

Weaknesses

Unfortunately, "while the company remains highly *****, its ***** health is increasingly tied to Lipi*****r" which is dangerous for the company in the future as Lipitor's patent will expire in several years, which means it ***** face competition from cheaper, generic drugs (*****, 2007). Pfizer's reputation has ***** been tainted by its association with Celebrex, a pain medication that has been tied to increased risk of heart problems, in comparison to over-the-counter painkillers. The prominence of the Pfizer advertising campaign for ***** drug, followed by ***** rapid f***** *****rom grace undoubtedly damaged the company's trusted name.

***** also manufactures Zoloft, an antidepressant that was widely criticized for its over-prescription to teenager, and possibly causing increased suicidal thoughts in this population. ***** company website now states that the drug is not advised for people under the age of 17. Antidepressants ***** 'lifestyle' ***** like Viagra have come ***** ********** media scrutiny and used as examples of the over-prescription of ***** in ***** American *****care system in general. Healthcare in America is grow*****g more and ***** expensive, and insurance companies are being pressured to cut costs, including scaling back how much they pay for *****s.

Now, Exubera, "the first and so far only commercially available inhaled-insulin diabetes treatment," is on the verge ***** turning in***** an "expensive failure" as Pfizer "has been dogged by questions about its safety, cost ***** convenience" (Berenson, *****).

Opportunities

According to the ***** press release section of its website, discom*****t associated with fibromyaglia, a common chronic pain condition, has ***** shown ***** be signific*****tly reduced ***** a new drug developed by Pfizer c*****lled Lyrica, "according to study results presented ***** at the ***** Academy ***** Neurology annual meeting" ("Lyrica Significantly Reduced Pain," 2007, Press Release). Pfizer has ***** developed a new AIDS drug called Maraviroc, which is likely to considerably improve and extend the life of AIDS patients who take the drug, according ***** researchers at ***** University of Pittsburg and Columbia University (Altman & Pollock, *****).

Threats

***** Merck ***** Schering-Plough, two of Pfizer's greatest rivals, plan to combine forces and develop a medicine to rival Lipitor. "The planned drug, meant to reduce levels of the harmful type of cholesterol in two ways, could hit ***** market when ***** patent expires in a few *****" ("Merck and Schering-Plough Plan A*****her Cholesterol Drug,"

. . . . [END OF DISSERTATION PREVIEW]

Download complete paper (and others like it)    |    Order a one-of-a-kind, custom-written paper

© 2001–2016   |   Essay about Pfizer SWOT Pfizer—a SWOT Analysis Strengths Pfizer is One of   |   Thesis Paper Example